Making State of the Art Pharmaceutical Knowledge and Regulatory Science Available to a Broader Audience

PEARL RIVER, NY, January 31, 2020 /24-7PressRelease/ — PharScite, LLC, a pharmaceutical knowledge and regulatory services company focused on sharing pharmaceutical knowledge and supporting emerging companies with regulatory efforts, today announced signing of a License and Collaboration Agreement with Center for Professional Advancement (CfPA). The collaboration is aimed at making state of the art pharmaceutical knowledge and regulatory science available to the emerging markets that are striving to enter regulated markets. Under the agreement, PharScite receives licenses to bring world renowned courses developed and offered by CfPA and presented by the best in the industry experts.

PharScite has decades of experience in regulatory sciences related to drug development and approval of new and generic drugs in the US and Health Canada. In addition, PharScite has institutional experience in teaching quality and regulatory sciences in the USA. Sharif Ahmed, Vice President of Pharmaceutical Information and Regulatory Services of PharScite said “This agreement with CfPA is a significant recognition of PharScite’s core capabilities and reach in emerging markets, and will add significant value to both the companies.”

About PharScite:

PharScite is a privately held company, with core competences in Pharmaceutical technology, product development, technology transfer, regulatory sciences and services. The company was founded in 2010 (as PharmaServ) by leading regulatory experts and renamed in 2019.

For the original version of this press release, please visit here